JP2021502105A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502105A5 JP2021502105A5 JP2020526180A JP2020526180A JP2021502105A5 JP 2021502105 A5 JP2021502105 A5 JP 2021502105A5 JP 2020526180 A JP2020526180 A JP 2020526180A JP 2020526180 A JP2020526180 A JP 2020526180A JP 2021502105 A5 JP2021502105 A5 JP 2021502105A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- lysosomal
- polypeptide
- placenta
- lysosomal protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1718681.8 | 2017-11-13 | ||
| GBGB1718681.8A GB201718681D0 (en) | 2017-11-13 | 2017-11-13 | Protein engineered extracellular vesicles |
| PCT/EP2018/081122 WO2019092287A1 (en) | 2017-11-13 | 2018-11-13 | Protein engineered extracellular vesicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502105A JP2021502105A (ja) | 2021-01-28 |
| JP2021502105A5 true JP2021502105A5 (https=) | 2021-12-23 |
Family
ID=60788311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526180A Pending JP2021502105A (ja) | 2017-11-13 | 2018-11-13 | タンパク質操作された細胞外小胞 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20200399591A1 (https=) |
| EP (1) | EP3710022A1 (https=) |
| JP (1) | JP2021502105A (https=) |
| KR (1) | KR20200081487A (https=) |
| CN (1) | CN111601607A (https=) |
| AU (1) | AU2018363212A1 (https=) |
| BR (1) | BR112020007327A2 (https=) |
| CA (1) | CA3082299A1 (https=) |
| GB (1) | GB201718681D0 (https=) |
| IL (1) | IL274124A (https=) |
| MX (1) | MX2020004712A (https=) |
| RU (1) | RU2020119155A (https=) |
| SG (1) | SG11202004200PA (https=) |
| WO (1) | WO2019092287A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020152298A1 (en) * | 2019-01-24 | 2020-07-30 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Method for producing enzymes |
| EP3986429A4 (en) * | 2019-06-21 | 2023-07-19 | Entelexo Biotherapeutics Inc. | PLATFORMS, COMPOSITIONS, AND METHODS OF ADMINISTRATION OF THERAPEUTICS |
| CN114616344B (zh) * | 2019-10-28 | 2026-03-31 | 普赛尔根技术股份公司 | 用于绘制滚环扩增产物图谱的方法 |
| US20210322483A1 (en) | 2020-04-16 | 2021-10-21 | Ichilov Tech Ltd. | Cell-derived particles presenting heterologous cd24 and use thereof in therapy |
| US20210324339A1 (en) | 2020-04-16 | 2021-10-21 | Ichilov Tech Ltd. | Cell-derived particles presenting heterologous cd24 and use thereof in therapy |
| JP2023535632A (ja) | 2020-07-27 | 2023-08-18 | アンジャリウム バイオサイエンシズ エージー | Ｄｎａ分子の組成物、その作製方法、及びその使用方法 |
| CN112285195B (zh) * | 2020-10-27 | 2021-08-10 | 江南大学 | 一种牛奶外泌体的特征性糖蛋白标志物和牛奶外泌体的特征性标志物分离方法 |
| AU2022315530A1 (en) | 2021-07-20 | 2024-01-18 | Ags Therapeutics Sas | Extracellular vesicles from microalgae, their preparation, and uses |
| WO2023144127A1 (en) | 2022-01-31 | 2023-08-03 | Ags Therapeutics Sas | Extracellular vesicles from microalgae, their biodistribution upon administration, and uses |
| CN118973591A (zh) * | 2022-03-28 | 2024-11-15 | 合同会社博子科技 | 包含miR-140的药物组合物及其制备方法 |
| WO2023193665A1 (zh) * | 2022-04-07 | 2023-10-12 | 威海纽兰生物科技有限公司 | 基于细胞外囊泡酯酶响应药物递送载体及其制备方法和用途 |
| WO2023232976A1 (en) | 2022-06-03 | 2023-12-07 | Ags Therapeutics Sas | Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses |
| WO2024088808A1 (en) | 2022-10-24 | 2024-05-02 | Ags Therapeutics Sas | Extracellular vesicles from microalgae, their biodistribution upon intranasal administration, and uses thereof |
| WO2024107831A1 (en) * | 2022-11-15 | 2024-05-23 | Board Of Trustees Of Michigan State University | Use of extracellular vesicles as a molecular screening platform |
| WO2025176843A1 (en) | 2024-02-21 | 2025-08-28 | Ags Therapeutics Sas | Microalgae extracellular vesicle based gene therapy vectors (mev-gtvs), their preparation, and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3145493T3 (da) * | 2014-05-18 | 2022-10-31 | Childrens Medical Center | Fremgangsmåder og sammensætninger vedrørende exosomer |
| WO2016044947A1 (en) * | 2014-09-26 | 2016-03-31 | Exerkine Corporation | Exosomes useful to treat lysosomal storage disease |
| WO2016057755A1 (en) * | 2014-10-09 | 2016-04-14 | Anthrogenesis Corporation | Placenta-derived adherent cell exosomes and uses thereof |
| EP3307286B1 (en) * | 2015-06-12 | 2023-01-11 | Hudson Institute of Medical Research | Allogeneic mammalian amniotic exosomes for treating a fibrotic disease |
-
2017
- 2017-11-13 GB GBGB1718681.8A patent/GB201718681D0/en not_active Ceased
-
2018
- 2018-11-13 MX MX2020004712A patent/MX2020004712A/es unknown
- 2018-11-13 BR BR112020007327-0A patent/BR112020007327A2/pt not_active IP Right Cessation
- 2018-11-13 SG SG11202004200PA patent/SG11202004200PA/en unknown
- 2018-11-13 AU AU2018363212A patent/AU2018363212A1/en not_active Abandoned
- 2018-11-13 EP EP18811725.3A patent/EP3710022A1/en not_active Withdrawn
- 2018-11-13 JP JP2020526180A patent/JP2021502105A/ja active Pending
- 2018-11-13 US US16/763,145 patent/US20200399591A1/en not_active Abandoned
- 2018-11-13 WO PCT/EP2018/081122 patent/WO2019092287A1/en not_active Ceased
- 2018-11-13 RU RU2020119155A patent/RU2020119155A/ru unknown
- 2018-11-13 CN CN201880073582.2A patent/CN111601607A/zh active Pending
- 2018-11-13 KR KR1020207016874A patent/KR20200081487A/ko not_active Withdrawn
- 2018-11-13 CA CA3082299A patent/CA3082299A1/en active Pending
-
2020
- 2020-04-21 IL IL274124A patent/IL274124A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502105A5 (https=) | ||
| RU2020119155A (ru) | Внеклеточные везикулы, полученные путем белковой инженерии | |
| IL274125B (en) | Exosomes comprising rna therapeutics | |
| JP2021507682A5 (https=) | ||
| Lindberg et al. | Sequence of the Citrobacter freundii OS60 chromosomal ampCβ‐lactamase gene | |
| Sperr et al. | The human cardiac mast cell: localization, isolation, phenotype, and functional characterization | |
| US5760178A (en) | Human and rat variants of glycoprotein CD44 containing an additional extracellular domain associated with metastatic potential | |
| Brooks et al. | Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis | |
| CA2114965A1 (fr) | Catalyseur de reformage a la vapeur et sa methode de preparation | |
| Spalton | Bovine mastitis caused by Prototheca zopfii: a case study. | |
| Clary et al. | The Drosophila mitochondrial genome. | |
| EP2582726B1 (en) | Antibody derivatives | |
| Hay et al. | Alterations in molecular structure of renal mitochondria associated with cyclosporine A treatment. | |
| Letchford et al. | Isolation of C15: a novel antibody generated by phage display against mesenchymal stem cell-enriched fractions of adult human marrow | |
| CN103463645A (zh) | 一种鱼类溶藻弧菌抗独特型抗体基因工程疫苗及其制备方法 | |
| Cowman et al. | Effects of oral streptococci on electrophoretic properties of human salivary anionic proteins. | |
| US20230414755A1 (en) | Methods and compositions relating to genetically engineered cells expressing chimeric antigen receptors | |
| Khalil et al. | Extramedullary plasmacytoma of the orbit: case report with results of immunocytochemical studies. | |
| Graham et al. | Testicular fibrosis and cardiomegaly in Shwachman's syndrome. | |
| Ivanov et al. | Effective use of free thiols as scavengers for HF cocktails to deprotect bromo-and chloroacetylated synthetic peptides. | |
| Siemankowski et al. | Comparative studies on the structure and aggregative properties of the myosin molecule. I. The structure of the lobster myosin molecule. | |
| Le Meur et al. | Lymphoproliferative syndromes after renal transplantation | |
| Zenner | Monoclonal antibodies against surface antigens of laryngeal carcinoma cells (author's transl) | |
| Johnson et al. | Intermediate filaments of bovine pulmonary artery smooth muscle distribution, isolation and polypeptide composition. | |
| Weerkamp et al. | Surface hydrophobicity and surface free energy of Actinobacillus actinomycetemcomitans strains from human periodontitis. |